Results

Total Results: 979 records

Showing results for "medication".
Users also searched for: medication reconciliation

41. Archived: Final Research Plan: Aspirin to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    October 07, 2013 - to Prevent Cancer Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … , such as age, sex, race/ethnicity, baseline cancer risk † , comorbid conditions * , or concomitant medication … , such as age, sex, race/ethnicity, baseline cancer risk † , comorbid conditions * , or concomitant medication … A proposed Contextual Question on harms of concomitant medication use was integrated into the appropriate

42. Final Recommendation Statement: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
    September 28, 2021 - Recommendation Statement Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … Treatment or Intervention Interventions to manage preeclampsia, such as antihypertensive medication … the 2014 recommendation, the USPSTF recommended the use of low-dose aspirin (81 mg/d) as preventive medication … Benefits of Risk Assessment and Preventive Medication The USPSTF considered 18 randomized clinical … Harms of preventive medication There is adequate evidence to bound the harms of low-dose aspirin as

43. Final Research Plan: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-anxiety-children-adolescents
    March 29, 2022 - disorder/dysthymia, disruptive mood dysregulation disorder, premenstrual dysphoric disorder, substance/medication-induced … CBT plus medication would be eligible]) KQs 1, 3:  No comparator KQ 2:  Another screening instrument … study) KQs 4, 5:  No comparator, active intervention (i.e., comparative effectiveness); for example, medication … X vs. medication Y would not be eligible, nor would CBT plus medication X vs. … CBT plus medication Y KQ 4, 5 (anxiety and depression):  Treatment as usual comparator groups where

44. Final Research Plan: Depression and Suicide Risk in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-depression-suicide-risk-children-adolescents
    August 13, 2020 - disorder/dysthymia, disruptive mood dysregulation disorder, premenstrual dysphoric disorder, substance/medication-induced … CBT plus medication would be eligible]) KQs 1, 3: No comparator KQ 2: Another screening instrument … study) KQs 4, 5: No comparator, active intervention (i.e., comparative effectiveness); for example, medication … X vs. medication Y would not be eligible, nor would CBT plus medication X vs. … CBT plus medication Y KQ 4, 5 (anxiety and depression): Treatment as usual comparator groups where

45. Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
    September 26, 2019 - Research Plan Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … Comparisons Placebo or no treatment Any active substance or intervention (e.g., nonaspirin medication

46. Final Research Plan: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/falls-prevention-community-dwelling-older-adults-interventions
    July 21, 2022 - Exercise (supervised or unsupervised, individual or group) Multifactorial assessment and intervention Medication … The intervention name “medication management” was also changed to “medication modification/review” to

47. Archived: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
    January 10, 2017 - Final Recommendation Statement Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication … Preventive Medication Folic acid is the synthetic form of folate, a water-soluble B vitamin. … Benefits of Preventive Medication The USPSTF found convincing evidence that folic acid supplementation … Harms of Preventive Medication The USPSTF found adequate evidence that the harms to the mother or infant … benefits of folic acid supplementation differ by dosage or timing. 1 Potential Harms of Preventive Medication

48. Archived: Evidence Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
    March 15, 2009 - archived Evidence Summary Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication … by the end of the trial: 28% of diabetic patients in the aspirin group had discontinued use of the medication

49. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Recommendation Statement Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication … Preventive Medication Aspirin's anticlotting effect is useful for primary and secondary CVD prevention … The complexity of risk factors, medication use, and concomitant illness make it difficult to assess the … Preferences about taking aspirin: Persons who place a high value on avoiding long-term daily medication

50. Archived: Final Evidence Review: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review52/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication-2011
    July 15, 2011 - Final Evidence Review Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication … Preventive Services Task Force (USPSTF) recommended prophylactic ocular topical medication for the prevention … neonatorum has become rare in the United States since the implementation of providing universal preventive medication

51. Let’s Talk About It: Preventing HIV with PrEP (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/hiv-prep-prevention-discussion-guide.pdf
    August 22, 2023 - professional determine your risk for HIV, decide whether taking PrEP is right for you, and discuss which PrEP medication … PrEP (pre-exposure prophylaxis) is a medication that can help prevent you from getting HIV. … 2 Which PrEP medication is best for me? 3 How long does it take for PrEP to be effective? … PrEP Formulations and Medication Adherence There are currently several FDA-approved ways that people

52. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
    September 03, 2019 - Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and … Systematic Review for the USPSTF Medication Use for the Risk Reduction of Primary Breast Cancer in … Symptomatic effects (eg, vasomotor, musculoskeletal) varied by medication. … with placebo per 1000 women, assuming 5 years of medication use, were estimated when the meta-analysis … for medication Harms of medication 3 4 2 4 1 Reduced incidence of invasive breast cancer Other

53. Final Research Plan: Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
    October 21, 2021 - Final Research Plan Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication

54. Clinical Summary: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/EzrKKtG83uM-jEB3W3vkvm
    Ophthalmia Neonatorum Population Newborns Recommendation Provide prophylactic ocular topical medication … Grade: A Preventive Medication Erythromycin ophthalmic ointment is the only drug approved by

55. Archived: Evidence Summary: Screening for Dyslipidemia in Younger Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - Younger Adults Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication

56. Archived: Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan98/statin-use-in-adults-preventive-medication-november-2016
    May 02, 2014 - Research Plan Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication

57. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - Disease in Adults Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication … recommendation statement: statin use for the primary prevention of cardiovascular disease in adults: preventive medication … HbA1c <12% SBP <200 mm Hg DBP <110 mm Hg Not receiving any other lipid-lowering medication … and 15 to 300 mg/24 h in two 24-h samples) Blood pressure <160/100 mm Hg and no antihypertensive medication … TC <309 mg/dL or <193 mg/dL if previous MI No lipid lowering medication 4 y Moderate

58. Evidence Summary: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
    September 28, 2021 - Evidence Summary Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … adherence in the trials was the number of women who were found to be taking at least 80% of their treatment medication … statement: low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: preventive medication … RecommendationStatementFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication … Gastroschisis in Europe—a case-malformed-control study of medication and maternal illness during pregnancy

59. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/hEp2uYfD9KRhYTY5fGr8Tp
    October 15, 2018 - Summary of Recommendation and Evidence The USPSTF recommends prophylactic ocular topical medication for … Benefits of Preventive Medication The USPSTF found convincing evidence that ocular prophylaxis of newborns … Harms of Preventive Medication The USPSTF found convincing evidence that ocular prophylaxis of newborns … Potential Harms of Preventive Medication The USPSTF found no new data that would change its previous … Possible harms include the potential for antimicrobial resistance to treatment medication.

60. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - Evidence Summary: Aspirin Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication … by the disorder (that is, colorectal adenoma vs. colorectal cancer), study design, study sample, and medication … respectively), and both used self-reporting of outcomes in mailed questionnaires, as well as mailed medication